We are live on ! Find out more
PHIO icon

Phio Pharmaceuticals
PHIO

9 hedge funds and large institutions have $827K invested in Phio Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

291% more capital inflows, than outflows

Capital inflows: $668K | Capital outflows: $171K

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

13% more funds holding

Funds holding: 8 → 9 (+1)

3.55% more ownership

Funds ownership: 1.77% → 5.32% (+3.5%)

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GSA Capital Partners
GSA Capital Partners
United Kingdom
+$188K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$172K
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$158K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$58.9K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$47.5K

Top Sellers

Rank Fund Capital Flow
1
Virtu Financial
Virtu Financial
New York
-$77K
2
Renaissance Technologies
Renaissance Technologies
New York
-$43K
3
Citadel Advisors
Citadel Advisors
Florida
-$26K
4
HSBC Holdings
HSBC Holdings
United Kingdom
-$24K
5
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$1K

PHIO Hedge Fund Activity: Q4 2020 in Review

9 of the 5,679 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals (PHIO) for Q4 2020, worth a combined $827K — up 279% from $218K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new PHIO positions and 5 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.

The largest buyer was GSA Capital Partners, adding an estimated $188K. The largest seller was Virtu Financial, exiting entirely with an estimated $77K sold.

  • 9 institutional investors held Phio Pharmaceuticals (PHIO) as of Q4 2020, up from 8 in Q3 2020.
  • Funds reported $827K of Phio Pharmaceuticals stock for Q4 2020, up 279% quarter-over-quarter.
  • 6 funds opened new Phio Pharmaceuticals positions in Q4 2020 and 5 closed out, a net change of +1 holder.
  • The largest Phio Pharmaceuticals buyer in Q4 2020 was GSA Capital Partners, an estimated $188K added.
  • The largest Phio Pharmaceuticals seller in Q4 2020 was Virtu Financial, an estimated $77K sold.

Based on aggregated 13F filings for Q4 2020.